1,200
Participants
Start Date
August 7, 2019
Primary Completion Date
March 31, 2028
Study Completion Date
March 31, 2028
RECRUITING
Flinders Medical Center, Adelaide
RECRUITING
NYU Langone Health, New York
COMPLETED
Hershey Medical Center, Hershey
COMPLETED
University of North Carolina, Chapel Hill
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
University of Minnesota, Minneapolis
COMPLETED
Carle Cancer Center, Urbana
RECRUITING
M.D. Anderson Cancer Center, Houston
RECRUITING
Cedars-Sinai Medical Center, Los Angeles
RECRUITING
Oregon Health and Science University, Portland
RECRUITING
University of Washington, Seattle
RECRUITING
Dana Farber Cancer Institute, Boston
WITHDRAWN
St. Michael's Hospital, Toronto
Collaborators (2)
Early Detection Research Network
NETWORK
Clinical Genomics Pathology
INDUSTRY
VolitionRx
UNKNOWN
Department of Health and Human Services
FED
Great Lakes New England Clinical Validation Center
UNKNOWN
National Cancer Institute (NCI)
NIH
University of Michigan Rogel Cancer Center
OTHER